Matthew Gline

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ROIV

Current role

CEO, Board Member

8 calls Latest call 2025-11-10

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$725,000	$2,359,250	—	—	—	$11,940	$3,096,190
2024	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$725,000	$4,978,875	$157,577,851	—	—	$12,018	$163,293,744
2023	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$725,000	—	—	—	—	$13,189	$738,189
2022	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$725,000	$1,036,750	—	$47,206,737	—	$10,339	$48,978,825
2021	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$725,000	$710,500	$9,500,630	$19,513,106	—	$10,795	$30,460,032
2020	Roivant Sciences Ltd. (ROIV)	Chief Executive Officer	$350,000	$455,000	—	$7,497,000	—	$8,550	$8,310,550

Earnings-call appearances and filed executive appointments or departures, newest first.